scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1043701X |
P356 | DOI | 10.1371/JOURNAL.PONE.0143701 |
P932 | PMC publication ID | 4669130 |
P698 | PubMed publication ID | 26633878 |
P5875 | ResearchGate publication ID | 285595343 |
P2093 | author name string | Yang Huang | |
Wan Huang | |||
Bing-Tian Bi | |||
Kun-Yao Feng | |||
Jing-Dun Xie | |||
Wei-An Zeng | |||
Dong-Tai Chen | |||
Jia-Hao Pan | |||
P2860 | cites work | The influence of verapamil on serum digoxin concentration | Q70333541 |
Quinidine enhances digitalis toxicity at therapeutic serum digoxin levels | Q70669412 | ||
Inhibition and induction of cytochrome P450 and the clinical implications | Q77634762 | ||
Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin | Q83908582 | ||
Cytochrome p450 inhibitory properties of common efflux transporter inhibitors | Q87045457 | ||
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection | Q25257484 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion | Q28259271 | ||
Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
Anthracenedione derivative 1403P-3 induces apoptosis in KB and KBv200 cells via reactive oxygen species-independent mitochondrial pathway and death receptor pathway | Q33296974 | ||
Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function | Q33559358 | ||
Biochemical, cellular, and pharmacological aspects of the multidrug transporter | Q33636699 | ||
Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin. | Q33887999 | ||
The role of metabolic activation in drug-induced hepatotoxicity | Q34410432 | ||
Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance | Q34550042 | ||
In vitro and in vivo drug interactions involving human CYP3A. | Q34663451 | ||
Paclitaxel-induced apoptosis is BAK-dependent, but BAX and BIM-independent in breast tumor | Q34663927 | ||
Role of P-glycoprotein in pharmacokinetics: clinical implications | Q35029495 | ||
Importance of P-glycoprotein at blood-tissue barriers | Q35847121 | ||
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2 | Q36016398 | ||
Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo. | Q36057369 | ||
Opioid Analgesics and P-Glycoprotein Efflux Transporters: A Potential Systems-Level Contribution to Analgesic Tolerance | Q36107418 | ||
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein | Q36166672 | ||
Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance? | Q37853578 | ||
A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. | Q37895002 | ||
A review of epidural and intrathecal opioids used in the management of postoperative pain | Q38026527 | ||
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation | Q38075335 | ||
Treatment paradigms for patients with metastatic non-small cell lung cancer, squamous lung cancer: first, second, and third-line | Q38229049 | ||
Potential risk of mulberry-drug interaction: modulation on P-glycoprotein and cytochrome P450 3A. | Q39165466 | ||
Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1. | Q40561425 | ||
In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results | Q40826933 | ||
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. | Q40904151 | ||
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. | Q43739398 | ||
Cytochrome P450 drug interactions with statin therapy | Q44242864 | ||
Variable modulation of opioid brain uptake by P-glycoprotein in mice | Q44344008 | ||
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance | Q44687014 | ||
Pharmacokinetics of salvianolic acids after intravenous injection, with and without Panax quinquefolium protopanaxadiol saponins, in rats | Q46649445 | ||
Active transport of fentanyl by the blood-brain barrier. | Q48228612 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | paclitaxel | Q423762 |
hepatotoxicity | Q1349821 | ||
fentanyl | Q407541 | ||
P304 | page(s) | e0143701 | |
P577 | publication date | 2015-12-03 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice | |
P478 | volume | 10 |
Q38674530 | A review of drug-induced liver injury databases |
Q93142938 | Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose |
Q38762992 | Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma. |
Q92151855 | Pain Management in Patients with Multiple Myeloma: An Update |
Q89586637 | Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism |
Q60048905 | Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients |
Search more.